Hepatitis C virus RNA detection in serum and peripheral blood mononuclear cells of patients with hepatitis C

Table 1 Detection of serum anti-hepatitis C virus and hepatitis C virus RNA in serum and peripheral blood mononuclear cells of patients with hepatitis C

Groups	Cases	Anti-Hepatitis C virus (+)	Serum Hepatitis C virus RNA (+)	Peripheral blood mononuclear cells-Hepatitis C virus RNA (+)
		cases (%)	cases (%)	cases (%)
Acute hepatitis C	46	36 (78.3)	40 (86.9)d	15 (32.6)
Post-transfusive hepatitis C	-36	31 (86.1)f	32 (88.9)	14 (38.9)
Shronic hepatitis C	-10	5 (50.0)	8 (80.0)	1 (10.0)
Chronic hepatitis C	42	40 (95.7)a	34 (80.95)d	33 (78.57)bd
Anti-hepatitis C virus (+) only	18	18 (100)	5 (27.7)	2 (11.1)
Total	106	94 (88.7)	79 (74.5)	50 (47.2)

^aP < 0.05 vs Acute hepatitis C;

^bP < 0.01 vs Acute hepatitis C;

^dP < 0.01 vs Anti-hepatitis C virus (+) only;

^fP < 0.01 vs Shronic hepatitis C.

Table 2 Relationship of anti-hepatitis C virus and hepatitis C virus RNA in serum and peripheral blood mononuclear cells

Clinical type	Number (%)
Anti-HCV+ (S+, PBMC+)	46 (52.3)
Anti-HCV+ (S-, PBMC-)	12 (13.6)
Anti-HCV+ (S+, PBMC-)	16 (18.2)
Anti-HCV+ (S-, PBMC+)	2 (2.3)
Anti-HCV- (S+, PBMC+)	0
Anti-HCV- (S-, PBMC+)	0
Anti-HCV- (S+, PBMC-)	12 (13.6)

HCV: Hepatitis C virus S: serum; PBMC: Peripheral blood mononuclear cells